Company seeks to support patients and providers with access to more frequent checkups
COLUMBIA, Md., (October 9, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Pre-Seed Builder Fund investment in JuneBrain. Under the umbrella of TEDCO’s Social Impact Funds, the Pre-Seed Builder Fund invests in and provides support to Maryland-based technology companies led by founders from economically underserved backgrounds.
“JuneBrain is dedicated to improving access to advanced retinal imaging in both eye care and neurology,” said Samantha Scott, CEO of JuneBrain. “With TEDCO’s support, we’re accelerating toward FDA clearance and market launch, so patients can benefit from more accessible monitoring and earlier detection of disease—whether they’re in major hospitals or underserved communities.”
JuneBrain Inc., located in Baltimore, Md., focuses on both the ophthalmology and neurology sectors, as millions of individuals across the globe suffer from retinal and neurological diseases. Its mission is to offer unique solutions to address the gap of infrequent, objective monitoring. The company currently offers two products for investigational use only: a high-speed retinal imaging system nicknamed “Neuro-i SS-OCT,” and an artificial intelligence (AI) software product designed to automatically analyze retinal images for neurodegenerative disease, named the JuneBrain Reading Center.
“TEDCO is dedicated to supporting innovative technology and life sciences companies across the state,” said Jean Luc-Park, deputy chief investment officer & senior director of TEDCO’s Social Impact Funds. “Through these innovations, we look to empower the overall ecosystem, allow for further growth and provide access to more opportunities, like those that JuneBrain has taken advantage of.”
JuneBrain received previous investments from TEDCO through the Pre-Seed Builder Fund and the State Small Business Credit Initiative (SSBCI).
“As home to the best hospital in the nation, it comes as no surprise that entrepreneurs and researchers in the state are looking to disrupt current practices to allow for more convenient and cost-effective options for both patient and provider,” said TEDCO CEO, Troy LeMaile-Stovall. “Innovators looking to enhance, grow or start a business in the medical devices market, should consider the benefits that come with calling Maryland home.”
For more information, visit our page at https://www.tedcomd.com/funding.